Establishment and intra-/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation

Journal of Applied Toxicology

Volumn 33, Issue 11, 2013, Pages 1241-1250

  Onoue, Satomi ^a   Hosoi, Kazuhiro ^b   Wakuri, Shinobu ^c   Iwase, Yumiko ^d   Yamamoto, Toshinobu ^d   Matsuoka, Naoko ^d   Nakamura, Kazuichi ^e   Toda, Tsuguto ^e   Takagi, Hironori ^f   Osaki, Naoto ^f   Matsumoto, Yasuhiro ^g   Kawakami, Satoru ^h   Seto, Yoshiki ^a,j   Kato, Masashi ^a   Yamada, Shizuo ^a   Ohno, Yasuo ⁱ   Kojima, Hajime ⁱ  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

^c HATANO RESEARCH INSTITUTE   (Japan)

^d MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^e SHIONOGI AND CO LTD   (Japan)

^f TAISHO PHARMACEUTICAL CO LTD   (Japan)

^g Grelan Pharmaceutical Co Ltd   (Japan)

^h ASAHI KASEI PHARMA CORPORATION   (Japan)

ⁱ NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^j KAKEN PHARMACEUTICAL CO LTD   (Japan)

more..

Author keywords

Inter laboratory precision; Photoreactivity; Phototoxicity; Reactive oxygen species; Validation

Indexed keywords

ACETYLSALICYLIC ACID; ACRIDINE; AMINOACRIDINE; AMIODARONE; ANTHRACENE; AVOBENZONE; BENZOCAINE; BITHIONOL; CHLORPROMAZINE; COUMARIN DERIVATIVE; DOXYCYCLINE; FENOFIBRATE; FUROSEMIDE; HEXACHLOROPHENE; KETOPROFEN; METHOXSALEN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PIROXICAM; PROMETHAZINE; QUININE; REACTIVE OXYGEN METABOLITE; ROSE BENGAL; ROSIGLITAZONE; SINGLET OXYGEN; SULISOBENZONE; SUPEROXIDE; TETRACYCLINE; UNINDEXED DRUG; BENZOPHENONE DERIVATIVE; DRUG;

ARTICLE; ASSAY; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LABORATORY; MULTICENTER STUDY; NONHUMAN; PHOTOTOXICITY; PREDICTION; PRIORITY JOURNAL; RADIATION EXPOSURE; ULTRAVIOLET IRRADIATION; VALIDATION STUDY; ADVERSE DRUG REACTION; ADVERSE EFFECTS; CHEMISTRY; DERMATITIS, PHOTOTOXIC; METABOLISM; PHOTOCHEMISTRY; RADIATION RESPONSE; REPRODUCIBILITY; STANDARD; STANDARDS; ULTRAVIOLET RADIATION;

BENZOPHENONES; DERMATITIS, PHOTOTOXIC; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; LABORATORIES; PHARMACEUTICAL PREPARATIONS; PHOTOCHEMICAL PROCESSES; QUININE; REACTIVE OXYGEN SPECIES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; ULTRAVIOLET RAYS; VALIDATION STUDIES AS TOPIC;

EID: 84884700623     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2776     Document Type: Article

References (34)

1. Barratt MD, Castell JV, Miranda MA, Langowski JJ. 2000. Development of an expert system rulebase for the prospective identification of photoallergens. J. Photochem. Photobiol. B 58: 54-61.
2. Brendler-Schwaab S, Czich A, Epe B, Gocke E, Kaina B, Muller L, Pollet D, Utesch D. 2004. Photochemical genotoxicity: principles and test methods. Report of a GUM task force. Mutat. Res. 566: 65-91.
3. Durbize E, Vigan M, Puzenat E, Girardin P, Adessi B, Desprez PH, Humbert PH, Laurent R, Aubin F. 2003. Spectrum of cross-photosensitization in 18 consecutive patients with contact photoallergy to ketoprofen: associated photoallergies to non-benzophenone-containing molecules. Contact Dermatitis 48: 144-149.
4. Epstein JH, Wintroub BU. 1985. Photosensitivity due to drugs. Drugs 30: 42-57.
5. Henry B, Foti C, Alsante K. 2009. Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule? J. Photochem. Photobiol. B 96: 57-62.
6. Holmes AM, Creton S, Chapman K. 2010. Working in partnership to advance the 3Rs in toxicity testing. Toxicology 267: 14-19.
7. Huvaere K, Skibsted LH. 2009. Light-induced oxidation of tryptophan and histidine. Reactivity of aromatic N-heterocycles toward triplet-excited flavins. J. Am. Chem. Soc. 131: 8049-8060.
8. Marin ML, Miguel A, Santos-Juanes L, Arques A, Amat AM, Miranda MA. 2007. Involvement of triplet excited states in the electron transfer photodegradation of cinnamic acids using pyrylium and thiapyrylium salts as photocatalysts. Photochem. Photobiol. Sci. 6: 848-852.
9. Moore DE. 2002. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf. 25: 345-372.
10. Motley RJ, Reynolds AJ. 1989. Photocontact dermatitis due to isopropyl and butyl methoxy dibenzoylmethanes (Eusolex 8020 and Parsol 1789). Contact Dermatitis 21: 109-110.
11. Onoue S, Tsuda Y. 2006. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharm. Res. 23: 156-164.
12. Onoue S, Igarashi N, Kitagawa F, Otsuka K, Tsuda Y. 2008a. Capillary electrophoretic studies on the photogenotoxic potential of pharmaceutical substances. J. Chromatogr. A 1188: 50-56.
13. Onoue S, Igarashi N, Yamada S, Tsuda Y. 2008b. High-throughput reactive oxygen species (ROS) assay: An enabling technology for screening the phototoxic potential of pharmaceutical substances. J. Pharm. Biomed. Anal. 46: 187-193.
14. Onoue S, Kawamura K, Igarashi N, Zhou Y, Fujikawa M, Yamada H, Tsuda Y, Seto Y, Yamada S. 2008c. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates. J. Pharm. Biomed. Anal. 47: 967-972.
15. Onoue S, Yamauchi Y, Kojima T, Igarashi N, Tsuda Y. 2008d. Analytical studies on photochemical behavior of phototoxic substances; effect of detergent additives on singlet oxygen generation. Pharm. Res. 25: 861-868.
16. Onoue S, Seto Y, Gandy G, Yamada S. 2009. Drug-induced phototoxicity; an early in vitro identification of phototoxic potential of new drug entities in drug discovery and development. Curr. Drug Saf. 4: 123-136.
17. Onoue S, Ochi M, Gandy G, Seto Y, Igarashi N, Yamauchi Y, Yamada S. 2010. High-throughput screening system for identifying phototoxic potential of drug candidates based on derivatives of reactive oxygen metabolites. Pharm. Res. 27: 1610-1619.
18. Peters B, Holzhutter HG. 2002. In vitro phototoxicity testing: development and validation of a new concentration response analysis software and biostatistical analyses related to the use of various prediction models. ATLA 30: 415-432.
19. Portes P, Pygmalion MJ, Popovic E, Cottin M, Mariani M. 2002. Use of human reconstituted epidermis Episkin for assessment of weak phototoxic potential of chemical compounds. Photodermatol. Photoimmunol. Photomed. 18: 96-102.
20. Puglia C, Bonina F, Rizza L, Blasi P, Schoubben A, Perrotta R, Tarico MS, Damiani E. 2012. Lipid nanoparticles as carrier for octyl-methoxycinnamate: in vitro percutaneous absorption and photostability studies. J. Pharm. Sci. 101: 301-311.
21. Ray RS, Mehrotra S, Prakash S, Joshi PC. 1996. Ultraviolet radiation-induced production of superoxide radicals by selected antibiotics. Drug Chem. Toxicol. 19: 121-130.
22. Selvaag E. 1997. Evaluation of phototoxic properties of oral antidiabetics and diuretics. Photohemolysis model as a screening method for recognizing potential photosensitizing drugs. Arzneimittelforschung 47: 1031-1034.
23. Seto Y, Inoue R, Ochi M, Gandy G, Yamada S, Onoue S. 2011. Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones. AAPS J. 13: 482-492.
24. Seybold PG, Gouterman M, Callis J. 1969. Calorimetric, photometric and lifetime determinations of fluorescence yields of fluorescein dyes. Photochem. Photobiol. 9: 229-242.
25. Spielmann H. 1994. In vitro phototoxicity testing. The report and recommendations of ECVAM Workshop 2. ATLA 22: 314-348.
26. Spielmann H, Balls M, Brand M, Doring B, Holzhutter HG, Kalweit S, Klecak G, Eplattenier HL, Liebsch M, Lovell WW, Maurer T, Moldenhauer F, Moore L, Pape WJ, Pfanenbecker U, Potthast J, De Silva O, Steiling W, Willshaw A. 1994a. EEC/COLIPA project on in vitro phototoxicity testing: first results obtained with a Balb/c 3T3 cell phototoxicity assay. Toxicol. in Vitro 8: 793-796.
27. Spielmann H, Liebsch M, Doring B, Moldenhauer F. 1994b. First results of an EC/COLIPA validation project of in vitro phototoxicity testing methods. ALTEX 11: 22-31.
28. Spielmann H, Liebsch M, Pape WJ, Balls M, Dupuis J, Klecak G, Lovell WW, Maurer T, De Silva O, Steiling W. 1995. EEC/COLIPA in vitro photoirritancy program: results of the first stage of validation. Curr. Probl. Dermatol. 23: 256-264.
29. Spielmann H, Balls M, Dupuis J. 1998a. The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial). Part 1: the 3T3 NRU phototoxicity test. Toxicol. in Vitro 12: 305-327.
30. Spielmann H, Balls M, Dupuis J, Pape WJ, Silva O, Holzhutter HG, Gerberick F, Liebsch M, Lovell WW, Pfannenbecker U. 1998b. A study on UV filter chemicals from Annex VII of Euroepan Union Directive 76/768/EEC, in the in vitro 3T3 NRU phototoxicity test. ATLA 26: 679-708.
31. Stein KR, Scheinfeld NS. 2007. Drug-induced photoallergic and phototoxic reactions. Expert Opin. Drug Saf. 6: 431-443.
32. Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. 2006. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol. Pharm. 3: 631-643.
33. Trevisi P, Vincenzi C, Chieregato C, Guerra L, Tosti A. 1994. Sunscreen sensitization: a three-year study. Dermatology 189: 55-57.
34. Yuan F, Hu C, Hu X, Qu J, Yang M. 2009. Degradation of selected pharmaceuticals in aqueous solution with UV and UV/H(2)O(2). Water Res. 43: 1766-1774.